GlassScriptPhysician profile
Julia W Johansson
NPI 1174546998
$388.22
in general payments reported to CMS, 2019-2025
14 companies · $52.62 in 2025
The $52.62 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.27 · 2020: $88.58 · 2021: $36.72 · 2022: $40.99 · 2023: $29.68 · 2024: $94.36 · 2025: $52.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145 · Long Term Medical Supply Or Device Loan: $32.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.58 |
| Long Term Medical Supply Or Device Loan | $32.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $59.19 | 2024-2025 | Hillrom - Spot Vision Screener, Perclot |
| Abbvie INC. | $57.18 | 2020-2023 | |
| Hologic Sales and Service, LLC | $46.89 | 2020-2022 | |
| Allergan, INC. | $41.17 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $25.51 | 2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $24.27 | 2020 | |
| Evofem Biosciences, INC. | $20.37 | 2021 | |
| Therapeuticsmd, INC. | $18.60 | 2020 | |
| Astellas Pharma US INC | $16.53 | 2024 | Veozah |
| Roche Diagnostics Corporation | $16.41 | 2019 | |
| Becton, Dickinson and Company | $16.40 | 2024 | Bd Onclarity |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Organon LLC | $14.69 | 2024 | |
| Coopersurgical, INC. | $14.66 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Johansson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.